Paul Kwo
Director of Hepatology, Stanford University · Stanford Health Care
Credentials: · · · · ·
History
- Present
Digestive Health Division · Stanford Health Care
- Present
- Present
- 1995–1996
Transplant Hepatology
- 1992–1995
Mayo Clinic Graduate Medical Education (1995) MN
- 1992–1995
Mayo Clinic Graduate Medical Education (1995) MN
Research
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
New England Journal of Medicine · 2014 · 1,431 citations
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection
New England Journal of Medicine · 2014 · 1,119 citations
ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries
The American Journal of Gastroenterology · 2017 · First of 3 authors · 897 citations
18 papers · 5 as a fellow
18 papers
- MS
17 papers
16 papers · 3 as a fellow
- WK
15 papers
- KR
14 papers
13 papers
13 papers
Grants
- 1997–1999
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $70.3K · Indiana University Indianapolis
Clinical trials
- 2013–2014
Principal investigator · Completed · Early phase 1
Indiana University
- 2007–2008
Study of Telaprevir in Subjects With Hepatic Impairment
Principal investigator · Completed · Phase 1
Vertex Pharmaceuticals Incorporated
- 2023–2034
National Liver Cancer Screening Trial
Site PI · Recruiting · Phase 4
University of Texas Southwestern Medical Center
- 2023–2031
Site PI · Recruiting · Phase 3
Takeda